

Dan Loeb’s Third Point acquired approximately 85,000 Bausch + Lomb shares worth about $1.4 million as of June 30, according to the filing.
You can purchase shares of Bausch & Lomb (NYSE:BLCO) through any online brokerage.
Other companies in Bausch & Lomb’s space includes: Medline Inc (NASDAQ:MDLN), Alcon Inc (NYSE:ALC), Solventum Corp (NYSE:SOLV), Align Technology Inc (NASDAQ:ALGN) and The Cooper Companies Inc (NASDAQ:COO).
Bausch & Lomb has a consensus price target of $20.12.
The stock price for Bausch & Lomb (NYSE: BLCO) is $21.26 last updated November 11, 2026 at 5:56 PM EST.
There are no upcoming dividends for Bausch & Lomb.
Bausch & Lomb does not have any upcoming earnings scheduled.
There is no upcoming split for Bausch & Lomb.
Bausch & Lomb is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical,...